| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1038868987 |
| P356 | DOI | 10.1245/S10434-011-2132-2 |
| P698 | PubMed publication ID | 22071867 |
| P5875 | ResearchGate publication ID | 51788725 |
| P50 | author | Pierluigi Pilati | Q59160039 |
| P2093 | author name string | Simone Mocellin | |
| Donato Nitti | |||
| Marta Briarava | |||
| Enzo Mammano | |||
| Loris Bertazza | |||
| Giorgio Zavagno | |||
| Francesca Galdi | |||
| Emanuela Tessari | |||
| P2860 | cites work | Circulating Tumor Cells and Colorectal Cancer. | Q37796603 |
| Stem cells and their implications for colorectal cancer. | Q37835709 | ||
| Molecular markers in circulating tumour cells from metastatic colorectal cancer patients | Q42914366 | ||
| Predictive value of cancer stem-like cells and cancer-associated genetic markers for peritoneal recurrence of colorectal cancer in patients after curative surgery | Q42975623 | ||
| Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients | Q48381360 | ||
| Quantification of the completeness of follow-up. | Q52938972 | ||
| Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high-risk cutaneous melanoma. | Q54710156 | ||
| Circulating tumor cells: approaches to isolation and characterization | Q24631347 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Identification and expansion of human colon-cancer-initiating cells | Q27860627 | ||
| A human colon cancer cell capable of initiating tumour growth in immunodeficient mice | Q27860831 | ||
| Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival | Q33594454 | ||
| Surgery for colorectal liver metastases. | Q33834452 | ||
| Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases | Q33874670 | ||
| Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer. | Q34059673 | ||
| The role of adjuvant therapy after liver resection for colorectal cancer metastases | Q35008616 | ||
| Targeted therapy for colorectal cancer: mapping the way. | Q36160087 | ||
| Colorectal liver metastasis: towards the integration of conventional and molecularly targeted therapeutic approaches | Q36170395 | ||
| Circulating tumor cells: the 'leukemic phase' of solid cancers | Q36400649 | ||
| The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis. | Q36561415 | ||
| Multiple imputation: review of theory, implementation and software | Q36719605 | ||
| CD133 expression is an independent prognostic marker for low survival in colorectal cancer | Q36944002 | ||
| Current management of colorectal hepatic metastasis | Q37436486 | ||
| Genetic prognostic and predictive markers in colorectal cancer | Q37523207 | ||
| Integration of neoadjuvant and adjuvant chemotherapy in patients with resectable liver metastases from colorectal cancer | Q37592789 | ||
| Circulating tumor cells: evolving evidence and future challenges | Q37629390 | ||
| Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer | Q37681109 | ||
| Role of adjuvant therapy after resection of colorectal cancer liver metastases | Q37724550 | ||
| Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review | Q37730438 | ||
| Colon cancer stem cells: promise of targeted therapy. | Q37737414 | ||
| The management of resectable and unresectable liver metastases from colorectal cancer | Q37762424 | ||
| Circulating tumour cells in cancer patients: challenges and perspectives | Q37776363 | ||
| P433 | issue | 2 | |
| P921 | main subject | patient | Q181600 |
| neoplastic stem cells | Q1638475 | ||
| P304 | page(s) | 402-408 | |
| P577 | publication date | 2011-11-10 | |
| P1433 | published in | Annals of Surgical Oncology | Q2853069 |
| P1476 | title | Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis | |
| P478 | volume | 19 |
| Q36005675 | A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers. |
| Q38035206 | CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges |
| Q37990005 | CD133 as a target for colon cancer |
| Q36819568 | CD133: a cancer stem cells marker, is used in colorectal cancers |
| Q38181528 | Cancer stem cell characteristics of circulating tumor cells |
| Q36804351 | Cancer stem cells CD133 and CD24 in colorectal cancers in Northern Iran |
| Q58765438 | Characteristics of the portal vein thrombosis recurrence pattern without liver parenchymal invasion from colorectal cancer: a case report |
| Q35858695 | Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment |
| Q38697494 | Circulating tumor cells: what we know, what do we want to know about them and are they ready to be used in clinics? |
| Q38227766 | Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer |
| Q27024191 | Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research |
| Q50969685 | Clinical Relevance of a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR) Expression in Circulating Tumor Cells. |
| Q38254124 | Clinical impact of minimal cancer cell detection in various colorectal cancer specimens |
| Q47444582 | Co-expression of CD133(+)/CD44(+) in human colon cancer and liver metastasis |
| Q36646553 | Colorectal cancer biomarkers and the potential role of cancer stem cells |
| Q34441291 | Comparison of putative circulating cancer stem cell detection between the hepatic portal system and peripheral blood in colorectal cancer patients |
| Q36600679 | Detection of circulating tumor cells by p75NTR expression in patients with esophageal cancer |
| Q37039311 | Doxorubicin and 5-fluorouracil resistant hepatic cancer cells demonstrate stem-like properties |
| Q35933922 | Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancer |
| Q36646520 | Evidence-based Guidelines for Precision Risk Stratification-Based Screening (PRSBS) for Colorectal Cancer: Lessons learned from the US Armed Forces: Consensus and Future Directions |
| Q52864004 | Expression of Epithelial Mesenchymal Transition and Cancer Stem Cell Markers in Circulating Tumor Cells. |
| Q37042121 | Extracorporeal tumor cell filtration during extended liver surgery: first clinical use of leukocyte depletion filters--case series |
| Q38734877 | Gene expression profiling and DNA methylation analyses of CTCs |
| Q35741252 | Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis-Antibody Array and Intracellular Signaling Array |
| Q37501071 | Long-term prognostic impact of circulating tumour cells in gastric cancer patients |
| Q26850739 | Metastatic cancer stem cells: from the concept to therapeutics |
| Q90664719 | Pathophysiology of Tumor Cell Release into the Circulation and Characterization of CTC |
| Q50720110 | Patients with CD133-negative colorectal liver metastasis have a poor prognosis after hepatectomy. |
| Q39153136 | Polymeric microfluidic devices exhibiting sufficient capture of cancer cell line for isolation of circulating tumor cells |
| Q35721595 | Potentiated DNA Damage Response in Circulating Breast Tumor Cells Confers Resistance to Chemotherapy |
| Q86478397 | Predicting early intrahepatic recurrence after curative resection of colorectal liver metastases with molecular markers |
| Q61453118 | Prognostic Value of CD133 and SOX2 in Advanced Cancer |
| Q47721142 | Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study |
| Q34486212 | Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma |
| Q42585781 | Prognostic significance of isolated tumor cells in patients with colorectal cancer in recent 10-year studies |
| Q43484960 | Prognostic value of circulating CD133(+) cells in patients with gastric cancer |
| Q54286948 | RNA biomarkers in colorectal cancer. |
| Q53089693 | Report on the International Workshop 'Cancer stem cells: the mechanisms of radioresistance and biomarker discovery'. |
| Q34178481 | STAT3β controls inflammatory responses and early tumor onset in skin and colon experimental cancer models. |
| Q38045265 | The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy. |
| Q27022113 | The promise of circulating tumor cell analysis in cancer management |
| Q38915449 | Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients. |
Search more.